Associate Professor Miguel Enrique Rentería Rodríguez, Group Leader of Computational Neurogenomics at QIMR Berghofer Medical Research Institute, is working to transform how we detect, track, and treat complex brain conditions like Parkinson’s disease. Despite decades of research, these disorders remain poorly understood, and current clinical tools often fail to capture the full range of patient symptoms or predict disease progression.
To tackle this, A/Prof Rentería leads the Australian Parkinson’s Genetics Study, a nationwide initiative with over 20,000 participants. His team combines large-scale genetic data with cutting-edge digital health technologies, including wearable devices, to measure symptoms with unprecedented precision.
By uncovering the genetic and environmental factors driving disease progression, his research is enabling the development of better prediction tools and paving the way for personalised therapies. A key focus is building an integrated platform that merges digital biomarkers with genomic data—designed to accelerate research and improve everyday clinical care for people with neurological conditions.